2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline

C331H200N16OS — CID 157497983

IUPAC2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline
SMILESCC1(C)c2ccc(-c3ccc4c(ccc5ccc6ccccc6c54)c3)nc2-c2nc(-c3ccc4c(ccc5ccc6ccccc6c54)c3)ccc21.c1ccc2c(c1)c(-n1c3ccccc3c3ccccc31)cc1ccc3cc(-n4c5ccccc5c5ccccc54)ccc3c12.c1ccc2c(c1)ccc1ccc3cc(-c4ccc5ccc(-c6ccc7c(ccc8ccc9ccccc9c87)c6)nc5n4)ccc3c12.c1ccc2c(c1)ccc1ccc3cc(-c4ccc5ccc6ccc(-c7ccc8c(ccc9ccc%10ccccc%10c98)c7)nc6c5n4)ccc3c12.c1ccc2c(c1)ccc1ccc3cc(-c4nnc(-c5ccc6c(ccc7ccc8ccccc8c76)c5)o4)ccc3c12.c1ccc2c(c1)ccc1ccc3ccc(-c4nnc(-c5ccc6ccc7ccc8ccccc8c7c6c5)s4)cc3c12.c1ccc2nc(-c3ccc4c(ccc5cc(-c6ccc7ccccc7n6)c6ccccc6c54)c3)ccc2c1.c1ccc2nc(-c3ccc4ccc5cc(-c6ccc7ccccc7n6)c6ccccc6c5c4c3)ccc2c1
InChIInChI=1S/C49H32N2.C48H28N2.C44H26N2.C42H26N2.C38H22N2O.C38H22N2S.2C36H22N2/c1-49(2)41-23-25-43(35-19-21-39-33(27-35)17-15-31-13-11-29-7-3-5-9-37(29)45(31)39)50-47(41)48-42(49)24-26-44(51-48)36-20-22-40-34(28-36)18-16-32-14-12-30-8-4-6-10-38(30)46(32)40;1-3-7-39-29(5-1)9-11-31-13-17-35-27-37(19-23-41(35)45(31)39)43-25-21-33-15-16-34-22-26-44(50-48(34)47(33)49-43)38-20-24-42-36(28-38)18-14-32-12-10-30-6-2-4-8-40(30)46(32)42;1-3-7-36-27(5-1)9-11-29-13-15-32-25-34(17-21-38(32)42(29)36)40-23-19-31-20-24-41(46-44(31)45-40)35-18-22-39-33(26-35)16-14-30-12-10-28-6-2-4-8-37(28)43(30)39;1-2-16-36-35(15-1)41(44-39-19-9-5-13-33(39)34-14-6-10-20-40(34)44)26-28-22-21-27-25-29(23-24-30(27)42(28)36)43-37-17-7-3-11-31(37)32-12-4-8-18-38(32)43;1-3-7-31-23(5-1)9-11-25-13-15-27-21-29(17-19-33(27)35(25)31)37-39-40-38(41-37)30-18-20-34-28(22-30)16-14-26-12-10-24-6-2-4-8-32(24)36(26)34;1-3-7-31-23(5-1)9-15-27-17-11-25-13-19-29(21-33(25)35(27)31)37-39-40-38(41-37)30-20-14-26-12-18-28-16-10-24-6-2-4-8-32(24)36(28)34(26)22-30;1-5-11-32-24(7-1)17-19-34(37-32)26-15-13-23-14-16-27-22-31(35-20-18-25-8-2-6-12-33(25)38-35)28-9-3-4-10-29(28)36(27)30(23)21-26;1-5-11-32-23(7-1)16-19-34(37-32)26-15-18-28-25(21-26)13-14-27-22-31(29-9-3-4-10-30(29)36(27)28)35-20-17-24-8-2-6-12-33(24)38-35/h3-28H,1-2H3;1-28H;1-26H;1-26H;2*1-22H;2*1-22H
InChIKeyBYBDZDFSCSSDIA-UHFFFAOYSA-N
MW4449.42 g/mol
LogP89.56
Rot. Bonds16

About 2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline

2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline (PubChem CID 157497983) has the molecular formula C331H200N16OS and a molecular weight of 4449.42 g/mol. Its IUPAC name is 2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline.

Molecular Properties

Compound Name2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline
PubChem CID157497983
Molecular FormulaC331H200N16OS
Molecular Weight4449.42 g/mol
Exact Mass4445.58
IUPAC Name2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline
SMILESCC1(C)c2ccc(-c3ccc4c(ccc5ccc6ccccc6c54)c3)nc2-c2nc(-c3ccc4c(ccc5ccc6ccccc6c54)c3)ccc21.c1ccc2c(c1)c(-n1c3ccccc3c3ccccc31)cc1ccc3cc(-n4c5ccccc5c5ccccc54)ccc3c12.c1ccc2c(c1)ccc1ccc3cc(-c4ccc5ccc(-c6ccc7c(ccc8ccc9ccccc9c87)c6)nc5n4)ccc3c12.c1ccc2c(c1)ccc1ccc3cc(-c4ccc5ccc6ccc(-c7ccc8c(ccc9ccc%10ccccc%10c98)c7)nc6c5n4)ccc3c12.c1ccc2c(c1)ccc1ccc3cc(-c4nnc(-c5ccc6c(ccc7ccc8ccccc8c76)c5)o4)ccc3c12.c1ccc2c(c1)ccc1ccc3ccc(-c4nnc(-c5ccc6ccc7ccc8ccccc8c7c6c5)s4)cc3c12.c1ccc2nc(-c3ccc4c(ccc5cc(-c6ccc7ccccc7n6)c6ccccc6c54)c3)ccc2c1.c1ccc2nc(-c3ccc4ccc5cc(-c6ccc7ccccc7n6)c6ccccc6c5c4c3)ccc2c1
InChIInChI=1S/C49H32N2.C48H28N2.C44H26N2.C42H26N2.C38H22N2O.C38H22N2S.2C36H22N2/c1-49(2)41-23-25-43(35-19-21-39-33(27-35)17-15-31-13-11-29-7-3-5-9-37(29)45(31)39)50-47(41)48-42(49)24-26-44(51-48)36-20-22-40-34(28-36)18-16-32-14-12-30-8-4-6-10-38(30)46(32)40;1-3-7-39-29(5-1)9-11-31-13-17-35-27-37(19-23-41(35)45(31)39)43-25-21-33-15-16-34-22-26-44(50-48(34)47(33)49-43)38-20-24-42-36(28-38)18-14-32-12-10-30-6-2-4-8-40(30)46(32)42;1-3-7-36-27(5-1)9-11-29-13-15-32-25-34(17-21-38(32)42(29)36)40-23-19-31-20-24-41(46-44(31)45-40)35-18-22-39-33(26-35)16-14-30-12-10-28-6-2-4-8-37(28)43(30)39;1-2-16-36-35(15-1)41(44-39-19-9-5-13-33(39)34-14-6-10-20-40(34)44)26-28-22-21-27-25-29(23-24-30(27)42(28)36)43-37-17-7-3-11-31(37)32-12-4-8-18-38(32)43;1-3-7-31-23(5-1)9-11-25-13-15-27-21-29(17-19-33(27)35(25)31)37-39-40-38(41-37)30-18-20-34-28(22-30)16-14-26-12-10-24-6-2-4-8-32(24)36(26)34;1-3-7-31-23(5-1)9-15-27-17-11-25-13-19-29(21-33(25)35(27)31)37-39-40-38(41-37)30-20-14-26-12-18-28-16-10-24-6-2-4-8-32(24)36(28)34(26)22-30;1-5-11-32-24(7-1)17-19-34(37-32)26-15-13-23-14-16-27-22-31(35-20-18-25-8-2-6-12-33(25)38-35)28-9-3-4-10-29(28)36(27)30(23)21-26;1-5-11-32-23(7-1)16-19-34(37-32)26-15-18-28-25(21-26)13-14-27-22-31(29-9-3-4-10-30(29)36(27)28)35-20-17-24-8-2-6-12-33(24)38-35/h3-28H,1-2H3;1-28H;1-26H;1-26H;2*1-22H;2*1-22H
InChIKeyBYBDZDFSCSSDIA-UHFFFAOYSA-N
XLogP89.56
TPSA203.46 Ų
H-Bond Donors
H-Bond Acceptors18
Rotatable Bonds16
Heavy Atoms349
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5004449.42
LogP ≤ 589.56
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1018

Analyze 2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline?
The IUPAC name of 2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline (CID 157497983) is 2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline.
What is the SMILES notation for 2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline?
The canonical SMILES for 2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline is CC1(C)c2ccc(-c3ccc4c(ccc5ccc6ccccc6c54)c3)nc2-c2nc(-c3ccc4c(ccc5ccc6ccccc6c54)c3)ccc21.c1ccc2c(c1)c(-n1c3ccccc3c3ccccc31)cc1ccc3cc(-n4c5ccccc5c5ccccc54)ccc3c12.c1ccc2c(c1)ccc1ccc3cc(-c4ccc5ccc(-c6ccc7c(ccc8ccc9ccccc9c87)c6)nc5n4)ccc3c12.c1ccc2c(c1)ccc1ccc3cc(-c4ccc5ccc6ccc(-c7ccc8c(ccc9ccc%10ccccc%10c98)c7)nc6c5n4)ccc3c12.c1ccc2c(c1)ccc1ccc3cc(-c4nnc(-c5ccc6c(ccc7ccc8ccccc8c76)c5)o4)ccc3c12.c1ccc2c(c1)ccc1ccc3ccc(-c4nnc(-c5ccc6ccc7ccc8ccccc8c7c6c5)s4)cc3c12.c1ccc2nc(-c3ccc4c(ccc5cc(-c6ccc7ccccc7n6)c6ccccc6c54)c3)ccc2c1.c1ccc2nc(-c3ccc4ccc5cc(-c6ccc7ccccc7n6)c6ccccc6c5c4c3)ccc2c1.
What is the InChIKey of 2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline?
The InChIKey is BYBDZDFSCSSDIA-UHFFFAOYSA-N. The full InChI is InChI=1S/C49H32N2.C48H28N2.C44H26N2.C42H26N2.C38H22N2O.C38H22N2S.2C36H22N2/c1-49(2)41-23-25-43(35-19-21-39-33(27-35)17-15-31-13-11-29-7-3-5-9-37(29)45(31)39)50-47(41)48-42(49)24-26-44(51-48)36-20-22-40-34(28-36)18-16-32-14-12-30-8-4-6-10-38(30)46(32)40;1-3-7-39-29(5-1)9-11-31-13-17-35-27-37(19-23-41(35)45(31)39)43-25-21-33-15-16-34-22-26-44(50-48(34)47(33)49-43)38-20-24-42-36(28-38)18-14-32-12-10-30-6-2-4-8-40(30)46(32)42;1-3-7-36-27(5-1)9-11-29-13-15-32-25-34(17-21-38(32)42(29)36)40-23-19-31-20-24-41(46-44(31)45-40)35-18-22-39-33(26-35)16-14-30-12-10-28-6-2-4-8-37(28)43(30)39;1-2-16-36-35(15-1)41(44-39-19-9-5-13-33(39)34-14-6-10-20-40(34)44)26-28-22-21-27-25-29(23-24-30(27)42(28)36)43-37-17-7-3-11-31(37)32-12-4-8-18-38(32)43;1-3-7-31-23(5-1)9-11-25-13-15-27-21-29(17-19-33(27)35(25)31)37-39-40-38(41-37)30-18-20-34-28(22-30)16-14-26-12-10-24-6-2-4-8-32(24)36(26)34;1-3-7-31-23(5-1)9-15-27-17-11-25-13-19-29(21-33(25)35(27)31)37-39-40-38(41-37)30-20-14-26-12-18-28-16-10-24-6-2-4-8-32(24)36(28)34(26)22-30;1-5-11-32-24(7-1)17-19-34(37-32)26-15-13-23-14-16-27-22-31(35-20-18-25-8-2-6-12-33(25)38-35)28-9-3-4-10-29(28)36(27)30(23)21-26;1-5-11-32-23(7-1)16-19-34(37-32)26-15-18-28-25(21-26)13-14-27-22-31(29-9-3-4-10-30(29)36(27)28)35-20-17-24-8-2-6-12-33(24)38-35/h3-28H,1-2H3;1-28H;1-26H;1-26H;2*1-22H;2*1-22H.
What are the key properties of 2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline?
2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline has a molecular weight of 4449.42 g/mol, XLogP of 89.56, 16 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 2,5-bis(benzo[c]phenanthren-2-yl)-1,3,4-thiadiazole;4,12-bis(benzo[g]phenanthren-3-yl)-8,8-dimethyl-3,13-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2,7-bis(benzo[g]phenanthren-3-yl)-1,8-naphthyridine;2,5-bis(benzo[g]phenanthren-3-yl)-1,3,4-oxadiazole;2,9-bis(benzo[g]phenanthren-3-yl)-1,10-phenanthroline;9-(3-carbazol-9-ylbenzo[c]phenanthren-8-yl)carbazole;2-(2-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline;2-(3-quinolin-2-ylbenzo[c]phenanthren-8-yl)quinoline is sourced from PubChem (CID 157497983), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).